Biopharmaceutics and therapeutic potential of engineered nanomaterials.
about
Techniques for physicochemical characterization of nanomaterialsNLRP3 inflammasome activation in murine alveolar macrophages and related lung pathology is associated with MWCNT nickel contaminationNanomaterials, inflammation, and tissue engineeringMetallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis.Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrinProblems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effectsInteraction of curcumin nanoformulations with human plasma proteins and erythrocytesFunctionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers.Nano-titanium dioxide modulates the dermal sensitization potency of DNCB.Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.Behavior and Potential Impacts of Metal-Based Engineered Nanoparticles in Aquatic Environments.Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermiaNanotech: propensity in foods and bioactives.Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles."Extremely minimally invasive": recent advances in nanotechnology research and future applications in neurosurgery.Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery.Chemical mechanisms of the toxicological properties of nanomaterials: generation of intracellular reactive oxygen species.Nanomaterials for sample pretreatment prior to capillary electrophoretic analysis.Magnetite (Fe3O4) nanocrystals affect the expression of genes involved in the TGF-beta signalling pathway.Evaluating the suitability of using rat models for preclinical efficacy and side effects with inhaled corticosteroids nanosuspension formulations.Genotoxicity evaluation of zinc oxide nanoparticles in Swiss mice after oral administration using chromosomal aberration, micronuclei, semen analysis, and RAPD profile.Mitochondrial potential (ΔΨm) changes in single rat hepatocytes: the effect of orthovanadate nanoparticles doped with rare-earth elements.In-vitro and in-vivo comparison of T-OA microemulsions and solid dispersions based on EPDC.In VivoNanotoxicity Assays in Animal ModelsThe accurate localization of fluorescent nanoparticle Au–Ft in nu/nu mice kidneyGold Nanoparticles: Promising Nanomaterials for the Diagnosis of Cancer and HIV/AIDSStandardization of Alternative Methods for Nanogenotoxicity Testing inDrosophila melanogasterUsing Iron Nanoparticles: A Promising Link to Nanodosimetry
P2860
Q27009549-72AEA695-543C-4044-9645-496A6BCBB335Q28389971-415E9F08-A2B1-40F0-9485-7EC5C0F37F2CQ28391805-90AD3B02-8AEB-494C-BB24-4E10E405D554Q30494430-E7427FD1-74B2-4AC1-943E-695507632257Q33759720-D48EBCB1-BDEF-4D80-A9E9-1E60EE63F73BQ33947942-3D60F7D5-94B9-4AFF-A084-637554D5789FQ34607948-B31B0A1C-25BA-4527-A7C6-0DE420CE03C0Q35576287-3F325125-790D-49B8-B455-C4C5C94F7FA8Q36064150-5E5E110A-ACAF-4C85-8739-8C294D4795B0Q36641483-0B11D36B-7E6B-497F-90D2-F5E17AFC62EAQ36882074-8D666EBA-B926-4BD1-AABD-B021137FA755Q37628607-F5DB01C5-B26F-4DFD-9D17-64B1CDCE09EBQ37929553-E4AFE23C-DC2C-4E43-BD85-2942456DA91FQ37944845-8133EF85-FCE3-49F7-AD35-FF9FAAFCE3BDQ38078983-FB719B85-15D7-43C3-A7C2-13536F23A8E9Q38244857-5EB2F051-8D3F-4F4A-93E8-C4E1587EE77FQ38996439-16A6D6B4-C6F3-4CEB-ACF0-2E937F505313Q39121005-43F01763-8484-4CE0-96F9-0B6B82C05AB5Q39137879-024593B5-1C6D-4D4A-A519-1E7867030F5DQ39780745-E588E787-B4CB-410B-A41A-4F716DBF167BQ41543788-2A59667A-A95D-41FE-808C-4570A7C55DB4Q46300302-C699D2BD-74B3-437D-B1C8-939649B6DA16Q46795539-B85F05BD-2B6B-43F1-A3CA-F603A413C5F0Q54567021-F7554FB3-D14C-4499-B0DA-D1B7861A24D4Q57340615-6743C244-B0E9-45E3-8742-BEEBC577AF33Q58235075-06719A91-CAC0-4F2E-8BCF-1C9415557506Q58691596-789E7869-41C9-4E3B-8AD9-6B02E747874FQ59129127-F81D67BE-4F3A-4DA4-AEA7-034558AC2F48
P2860
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
@en
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
@nl
type
label
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
@en
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
@nl
prefLabel
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
@en
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
@nl
P2093
P2860
P1476
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
@en
P2093
Chunying Chen
Paul C Wang
Xing-Jie Liang
Yuliang Zhao
P2860
P304
P356
10.2174/138920008786049230
P407
P577
2008-10-01T00:00:00Z